Medical Devices Startups

Milbotix develops technology to help people with dementia and other conditions that impair communication of distress. The company brings together technologists, business executives, and clinical specialists focused on improving care and quality of life.

1 investor

Milestone Pharmaceuticals is a life sciences company that develops therapies for patients with cardiovascular and other diseases.

1 investor

Mimark is a biotechnology company developing diagnostic tools for gynecological diseases through biomarker research. The company aims to make testing less invasive and more precise for patients, clinicians, hospitals, and diagnostic manufacturers.

1 investor

Mimetogen is a biotechnology company developing novel therapeutics, with a focus on tavilermide for ophthalmic indications including dry eye disease. The company brings together expertise in drug discovery, development, and clinical research to advance treatment options in ophthalmology.

1 investor

Mimetrik is a dental technology spinout from the University of Leeds founded by practicing dentists, developing digital solutions for the clinical dental pathway. The company combines clinical expertise with experience in medical devices, regulatory compliance, and supply chain management.

1 investor

MiNA Therapeutics develops small activating RNA (RNAa) therapeutics, a new class of medicines designed to restore or enhance gene function for treating genetic diseases and other conditions. The company has a platform approach that advances proprietary drug candidates and collaborates with pharmaceutical companies across multiple therapeutic areas.

1 investor

MindAffect develops brain-computer interface technology that measures automatic neural responses to auditory and visual stimuli using EEG, enabling objective hearing and vision assessment for patients who cannot respond behaviorally (young children, individuals with disabilities, older adults). The company's Sofi Hearing Assessment System and vision-assessment platforms (KinderCap, GLAM, KinderGaze) are designed for clinical hearing and vision testing without requiring patient feedback.

1 investor

MindAhead is a CE-certified Class 1 medical device app offering a structured, evidence-based digital activation program with cognitive exercises and everyday activities for people experiencing memory problems, mild cognitive impairment, or mild dementia. It serves patients, their relatives, and physicians, and was evaluated in a clinical study across more than 20 memory clinics in Germany.

1 investor

Mindful Health Solutions is a provider of behavioral health care specializing in advanced psychiatric treatments including Transcranial Magnetic Stimulation (TMS), esketamine nasal spray, IV ketamine therapy, and emerging psychedelic therapies, primarily for treatment-resistant depression. Operating 21 clinics across California, Texas, and Washington, the company employs board-certified psychiatrists and uses data-driven protocols to deliver personalized mental health care.

1 investor

MindRhythm develops a portable, non-invasive medical device that uses the Headpulse algorithm and AI to triage stroke patients in the prehospital setting, helping paramedics identify Large Vessel Occlusion strokes and route patients to appropriate hospitals faster. The company targets emergency and neurological care providers in the stroke diagnostics market.

1 investor

Mindspan provides cognitive care through at-home screening and in-clinic evaluation by board-certified neurologists, reducing typical 18-month wait times to weeks for patients with memory changes, mild cognitive impairment, Alzheimer's disease, and other dementias. The platform combines diagnostic assessments with personalized treatment plans and ongoing family-centered support to address cognitive health conditions.

1 investor

Minerva Surgical is a women's health medical device company focused on technologies for conditions such as heavy menstrual bleeding, offering alternatives to hysterectomy. It provides support to clinical teams using its products.

1 investor

SCHOTT MINIFAB provides contract design, development, and manufacturing services for life science research and diagnostic consumables, including cleaned and coated substrates for in vitro diagnostics and research applications. It specializes in microarray, microfluidic, and injection molding techniques and serves product developers in the diagnostics and life science tools market, with production in the United States, Germany, and Australia.

1 investor

MintNeuro designs purpose-built, low-power integrated circuits for neural implants, supporting functions like neural signal acquisition, stimulation, power management, and on-chip signal processing. It works with medical-device companies, research institutions, and consortia building active implantable medical devices and brain-computer interfaces for conditions such as epilepsy, Parkinson's, dementia, and depression.

1 investor

Miphic provides imaging-based diagnostic screening of mitochondrial function to identify drug efficacy and personalized treatment options for cancer, neurodegenerative disease, diabetes, and aging-related conditions. The platform screens up to 96 conditions simultaneously to support drug discovery, personalized medicine selection, and metabolic research.

1 investor

Mirada develops medical imaging software solutions that personalize image-guided cancer treatment to improve patient outcomes. The company combines scientific advancement, technical innovation, and clinical expertise to accelerate cancer care delivery.

1 investor

MFC Co., Ltd. manufactures active pharmaceutical ingredients (APIs) and key starting materials, and conducts R&D and mass production in pharmaceuticals and materials. Using high-purity crystallization technology, it develops and supplies Statin-class APIs such as TBFA and TPPBr, focusing on domestic production of imported pharmaceutical ingredients in South Korea.

1 investor

Miramoon Pharma develops neuroprotective small molecule therapies targeting degenerative disorders including ophthalmology, skeletal and cardiac muscle diseases, and central nervous system conditions. The company was spun out from the University of the Basque Country and Biogipuzkoa Health Research Institute.

1 investor

Miraqules develops biomaterial-based wound healing products for point-of-care medical applications. The company creates affordable, fast-acting solutions including products like StopBleed and InstaBrin, targeting the global healthcare market.

1 investor

Mireca develops treatments for rare, inherited retinal degenerations based on scientific research originating from the EU-funded DRUGSFORD project. The company translates basic research into therapeutic candidates targeting photoreceptor degeneration diseases such as retinitis pigmentosa and achromatopsia.

1 investor

Miromatrix develops fully biologic organs using decellularization and recellularization technology for transplant patients. The company focuses on engineering transplantable kidneys, livers, and liver support devices to address the critical shortage of donor organs.

1 investor

MISO Chip develops microfluidic systems and diagnostic technologies for oncology, drug development, and precision medicine applications. The company serves biologists, physicians, and clinical researchers seeking to accelerate the translation of biomedical discoveries into patient treatments.

1 investor

Mission Driven Tech develops medical devices and educational content focused on cervical and uterine cancer treatment. The company offers brachytherapy devices for gynecological cancers and outcome research resources for healthcare professionals.

1 investor

MLA Diagnostics develops a melanoma diagnostic test based on DNA methylation biomarkers to improve patient risk stratification and treatment decisions. The company serves oncology practices and pathology labs in the cancer diagnostics market.

1 investor